Venus MedTech is a leading Chinese brand in the field of minimally invasive structural heart disease treatments. As pioneers in the industry, the company focuses on the development and commercialization of innovative medical devices for structural heart diseases. Their flagship product, VenusA-Valve, is the first transcatheter aortic valve replacement (TAVR) product approved by the National Medical Products Administration (NMPA) in China.

With a mission to